AcquisitionOther
Pfizer acquired Metsera, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Pfizer -> Metsera, Inc. · up to $86.25 per share
Acquiring important drug candidates to deliver immediate and substantial value to stockholders with high certainty of closing.
Open source record (SEC) ↗